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Short Communication
Proteome analysis enables separate clustering of normal breast,
benign breast and breast cancer tissues
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We have used proteomics with cluster analysis for the classification of breast tumour tissues. In our approach, we can distinguish
between normal breast, benign breast and breast cancer tissues on the basis of the protein expression profiles. We propose an
objective method for the classification of breast tumour specimens.
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Proteomics is the main tool for understanding the vast amount of
data generated from the human genome sequencing project.
Proteomics is defined as the characterisation of all proteins
encoded by the genome and allows identification of protein–
protein interactions and disease-associated proteins.
Proteomic studies mainly use two-dimensional electrophoresis
(2-DE) for protein separation and mass spectrometry for protein
identification. Using 2-DE, a mixture of proteins is separated first
on the basis of charge and second according to size. A typical 2-DE
system can separate up to 3000 protein spots per experiment.
Although this does not enable the entire proteome to be mapped in
a single experiment, it is recognised as being unparalleled in terms
of the data generated. In common with genetic microarray
analysis, however, there is a need to comprehend the meaning of
the vast amount of data that 2-DE experiments produce. Most
proteome studies use univariate analysis to compare the levels of a
protein spot in a cohort of diseased tissue samples compared with
normal tissues. A newer approach is a refinement of multivariate
analysis whereby expression levels of many proteins are compared
simultaneously. Various methods, such as neural network and
fuzzy logic have been proposed for this type of analysis (Alaiya
et al, 2002).
The aim of our work was to identify proteins to differentiate
between normal breast, benign breast and breast cancer tissue.
MATERIALS AND METHODS
A mini 2-DE procedure was used to separate proteins from 32
normal and pathological breast specimens as well as axillary lymph
node specimens removed following surgical excision.
The proteins were prepared and separated as described
previously (Weekes et al, 1999). Isoelectric focusing was
performed on nonlinear 3–10 IPG strips, 7cm in size. The
isoelectric focusing conditions were 10.5kVh with the voltage set
to 3000. The second-dimension gel electrophoresis was carried out
in the Atto AE-6450 vertical electrophoresis system at 130V for
2.5h in tank buffer. The second-dimension gels were 8cm in size
and were run at 170V for 1–1.5h until the bromophenol blue
marker had reached the bottom of the gel. After electrophoresis,
the proteins in the gels were visualised by staining with silver
nitrate using the PlusOne Protein Silver Staining Kit (Amersham
Biosciences, Bucks, UK). The data from the gels were then
imported into PDQuest software by laser-scanning densitometry
(Bio-Rad, Hemel Hempstead, UK).
Quantitative data sets were analysed using the J-Express
software (Alaiya et al, 2002). Hierarchical analysis allows samples
that are highly similar to be merged in an agglomerative way, using
the complete linkage clustering procedure. This grouping is
presented in the form of dendrograms with trees and branches
depicting the extent of similarities among the different groups in
the samples. To generate distinct sample clusters, variables were
selected using the Mann–Whitney statistical analysis between
normal breast tissue and benign breast tissue (Po0.05). A similar
analysis was conducted between groups of primary breast cancer
specimens and axillary lymph node metastases.
RESULTS
A total of 32 breast tissue samples were analysed by 2-DE; the
clinical and histological characteristics of the samples are shown in
Table 1.
The average number of resolved spots on the mini gels was
350 and the gel spots were matched between gels using a reference
gel. The reference gel is shown in Figure 1. In all, 16 breast tissue
samples, consisting of three normal breast, three benign breast
and 10 breast cancer, were initially analysed. A set of 132 spots
differed significantly between normal breast tissue and benign
breast tumours. This data set was used as the training set for
the cluster analysis and all 16 samples were correctly classified
(data not shown). We then tested if these markers could
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sdiscriminate new cases by adding seven samples and the result was
re-evaluated. All the 23 samples were correctly classified, as shown
in Figure 2A.
Next, we examined whether tumours with similar clinical
outcomes could be classified. A set of nine breast tumours and
MCF7, a breast cancer cell line, were added to the 23 samples. To
improve the classification, a second variable selection was made. A
total of 124 proteins were differentially expressed between primary
breast cancer and the axillary node metastases (Mann–Whitney,
Po0.05). This data set was then used for the hierarchical cluster
analysis of all the 33 samples consisting of the five different sub
groups. The dendogram produced from this analysis is presented
in Figure 2B. The majority of the normal and benign tissues
Table 1 Clinical and histopathological features of the specimens used in this study
Sample no. Tissue Age of patient Pathology
N1 Normal 57 Normal breast
N2 Normal 56 Normal breast
N3 Normal 24 Normal breast
N4 Normal 27 Normal breast
B1 Benign 42 Fibroadenoma
B2 Benign 18 Fibroadenoma
B3 Benign 28 Intraduct papillomatosis
B4 Benign 68 Intraduct papillomatosis
Sample no. Tissue Age of patient Pathology Size Grade LN status
C1 Cancer 52 Ductal carcinoma 19 G3 Not sampled
C2 Cancer 57 Ductal carcinoma 15 G3 0/6
C3 Cancer 77 Ductal carcinoma 20 G1 1/6
C4 Cancer 44 Ductal carcinoma 30 G2 1/17
C5 Cancer 70 Ductal carcinoma 20 Not stated 2/2
C6 Cancer 53 Ductal carcinoma 20 Not stated 3/8
C7 Cancer 51 Ductal carcinoma 100 G3 7/8
C8 Cancer 53 Ductal carcinoma 20 Not stated Not sampled
C9 Cancer 56 Ductal carcinoma 40 Not stated 2/5
C10 Cancer 56 Ductal carcinoma 30 G2 6/8
C11 Cancer 71 Ductal carcinoma 25 Not stated 0/2
C12 Cancer 68 Advanced ductal cancer 150 Not sampled Not sampled
C13 Cancer 79 Advanced ductal cancer 44 G3 4/4
C14 Cancer 78 Ductal carcinoma 28 G3 0/8
C15 Cancer 78
LN¼lymph node.
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First dimension: separation by isoelectric focusing
Figure 1 Reference gel showing proteins separated using two-dimen-
sional electrophoresis. The proteins are separated first according to their
isoelectric point and then separated according to size. The proteins were
visualised using a silver stain.
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Cluster analysis of all 23 samples consisting of 16 training and
seven test samples using the expression data from 132 proteins
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Figure 2 Cluster analysis of (A) 23 breast tumour samples using
expression data from 132 protein spots and (B) all 31 breast tissue samples
using expression data from 105 protein spots.
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exclusively of primary breast cancers, the third sub-branch
consisted of a mixture of lymph nodes with or without metastatic
breast cancer.
DISCUSSION
This is the first time that 2-DE has been used with hierarchical
cluster analysis for the classification of breast specimens, although
a previous report using cells grown in vitro suggested that such
analysis might be warranted (Harris et al, 2002).
We used mini-2-DE gels for the proteome analysis because the
technology is rapid, simple and sensitive, making it especially
applicable for routine diagnostic purposes. One disadvantage is
that relatively few proteins could be resolved on mini gels. Clearly,
the use of large size gels capable of resolving between 1000 and
2000 proteins in one experiment would have provided further data.
It is tempting to speculate that the use of such gels would have
enabled improved clustering, for example it may have separated
the breast cancer cases according to the stage of their disease at
presentation. The use of large gels, however, requires availability of
larger amounts of starting material. We found that the small gel
format was of sufficient resolution for cluster analysis to be
performed, resulting in the separation of normal and benign breast
tissue from breast cancer specimens on the basis of their protein-
spot expression patterns.
A useful aspect of this analysis is that it allows the identification
of the spots that contribute to the overall clustering. It seems
unlikely, however, that a universal set of proteins will discriminate
between different subgroups in a cohort of samples and it will be
interesting to discover if training sets of selected variables remain a
prerequisite for efficient sample classification. In this study, 33
spots were common to both dendrograms and when evaluated
separately, these proteins enabled clustering of almost all the
samples, therefore, these protein spots are obvious candidates for
further study.
In summary, we have used mini-2-DE to separate proteins from
breast tissue samples and found that hierarchical cluster analysis
enabled discrimination between normal breast, benign breast
tissue and breast cancer tissue specimens according to their
protein expression profiles.
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